We’ve previously championed the information technology (IT) sector. However, we think room for growth in the IT sector is currently limited and, as a result, we think the outlook for growth could be challenging.
In some ways, we view the pharmaceutical sector in a similar way we view the IT sector. Indian pharmaceutical companies that sought to gain market share in the vast US pharmaceuticals space have found themselves with limited room for expansion. Short-term issues, including manufacturer disputes, have had some detrimental impact on the sector. As a result, we expect longer-term growth to be much lower compared with what we’ve seen over the last 10 years.